SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (1505)2/11/1999 8:24:00 PM
From: Anthony@Pacific  Read Replies (3) of 2135
 
ENMD<--------SELL/SHORT @ 26 1/2 ( stock should trade around 7 to 8 based on 4 times cash )

Lets be realistic ..they are years away from any thing that could possibly even come close to helping humansand are a decade away from any commercial use...We saw this before and we know what happened last time...The Bristol Myers news killed it and should not be discounted ..There are those on this thread who claim to know more than the powers that be at Bristol Myers....Now In all honesty I was more impressed with GERN's stem cell studies about being able to regenerate tissue and the prospect of immortal cells..ENMD is nothing but a pipe dream at this point in time and I have initiated coverage of this stock at current levels with an immediate Sell/SHORT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext